Sensei Biotherapeutics, Inc. (SNSE)
NASDAQ: SNSE · Real-Time Price · USD
0.3660
+0.0210 (6.09%)
At close: Apr 2, 2025, 4:00 PM
0.3294
-0.0367 (-10.01%)
After-hours: Apr 2, 2025, 7:28 PM EDT
Sensei Biotherapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
28
Market Cap
9.23M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
SNSE News
- 12 hours ago - Sensei Biotherapeutics to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference - GlobeNewsWire
- 5 days ago - Sensei Biotherapeutics Reports Full Year 2024 Financial Results and Update on Clinical Progress - GlobeNewsWire
- 6 days ago - Sensei Biotherapeutics Reports Favorable Preliminary Dose Expansion Data for Solnerstotug in PD-(L)1 Resistant Tumors - GlobeNewsWire
- 2 months ago - Sensei Biotherapeutics to Participate in Oppenheimer's 35th Annual Healthcare Life Sciences Conference - GlobeNewsWire
- 3 months ago - Sensei Biotherapeutics Provides Corporate Update and Highlights Key Upcoming Milestones - GlobeNewsWire
- 4 months ago - Sensei Biotherapeutics to Participate in Citi's 2024 Global Healthcare Conference - GlobeNewsWire
- 4 months ago - Sensei Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewsWire
- 5 months ago - Sensei Biotherapeutics to Present at Two Upcoming Scientific Conferences - GlobeNewsWire